Jane Street Group LLC Acquires 3,932 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Jane Street Group LLC boosted its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 18.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,556 shares of the company's stock after acquiring an additional 3,932 shares during the quarter. Jane Street Group LLC's holdings in Henry Schein were worth $1,768,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Olstein Capital Management L.P. boosted its holdings in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after acquiring an additional 16,000 shares during the period. Private Management Group Inc. boosted its stake in shares of Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after purchasing an additional 18,882 shares during the period. Equitable Trust Co. bought a new position in shares of Henry Schein in the fourth quarter worth approximately $417,000. Savant Capital LLC grew its holdings in shares of Henry Schein by 43.9% in the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after purchasing an additional 1,420 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Henry Schein by 29.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after buying an additional 3,650 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Activity

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.08% of the company's stock.

Henry Schein Stock Down 1.4%

Henry Schein stock traded down $1.05 during trading hours on Wednesday, hitting $72.08. 2,097,786 shares of the stock traded hands, compared to its average volume of 1,648,185. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The firm's 50-day moving average price is $67.44 and its two-hundred day moving average price is $71.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.77 billion, a PE ratio of 29.66, a PEG ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter last year, the business posted $1.10 EPS. On average, research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on HSIC. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Piper Sandler cut their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Finally, Barrington Research dropped their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Henry Schein currently has an average rating of "Moderate Buy" and a consensus target price of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.